Hydroxyurea does not appreciably reduce JAK2 V617F allele burden in patients with polycythemia vera or essential thrombocythemia, Haematologica, vol.95, pp.1435-1438, 2010. ,
Alvarez-Larr an, A., Mart ?nez-Avil es ,
Modulation of JAK2 V617F allele burden dynamics by hydroxycarbamide in polycythaemia vera and essential thrombocythaemia patients: JAK2 V617F Modulation by Hydroxyurea, British Journal of Haematology, vol.152, pp.413-419, 2011. ,
Presence of atypical thrombopoietin receptor (MPL) mutations in triple-negative essential thrombocythemia patients, Blood, vol.127, pp.333-342, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01258942
Oncogenic activation of MPL/thrombopoietin receptor by 17 mutations at W515: implications for myeloproliferative neoplasms, Leukemia, vol.30, pp.1214-1216, 2016. ,
Substitution of pseudokinase domain residue Val-617 by large non-polar amino acids causes activation of JAK2, Journal of Biological Chemistry, vol.283, pp.12941-12948, 2008. ,
Mutation profile of JAK2 transcripts in patients with chronic myeloproliferative neoplasias, The Journal of Molecular Diagnostics, vol.11, pp.49-53, 2009. ,
MPL mutation profile in JAK2 mutation-negative patients with myeloproliferative disorders, Diagnostic Molecular Pathology, vol.20, pp.34-39, 2011. ,
Germ-line JAK2 mutations in the kinase domain are responsible for hereditary thrombocytosis and are resistant to JAK2 and HSP90 inhibitors, Blood, vol.123, pp.1372-1383, 2014. ,
Germline JAK2 mutation in a family with hereditary thrombocytosis, The New England Journal of Medicine, vol.366, pp.967-969, 2012. ,
Impact of isolated germline JAK2V617I mutation on human hematopoiesis, Blood, vol.121, pp.4156-4165, 2013. ,